Linkeviciute Alma, Canario Rita, Peccatori Fedro Alessandro, Dierickx Kris
Legal Tech Center, Mykolas Romeris University, LT-08303 Vilnius, Lithuania.
Fertility and Procreation Unit, Division of Gynecologic Oncology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Cancers (Basel). 2022 Sep 3;14(17):4325. doi: 10.3390/cancers14174325.
(1) Background: Current scientific evidence suggests that most cancers, including breast cancer, can be treated during pregnancy without compromising maternal and fetal outcomes. This, however, raises questions regarding the ethical implications of clinical care. (2) Methods: Using a systematic literature search, 32 clinical practice guidelines for cancer treatment during pregnancy published between 2002 and 2021 were selected for analysis and 25 of them mentioned or made references to medical ethics when offering clinical management guidance for clinicians. (3) Results: Four bioethical themes were identified: respect for patient's autonomy, balanced approach to maternal and fetal beneficence, protection of the vulnerable and justice in resource allocation. Most guidelines recommended informing the pregnant patient about available evidence-based treatment options, offering counselling and support in the process of decision making. The relational aspect of a pregnant patient's autonomy was also recognized and endorsed in a significant number of available guidelines. (4) Conclusions: Recognition and support of a patient's autonomy and its relational aspects should remain an integral part of future clinical practice guidelines. Nevertheless, a more structured approach is needed when addressing existing and potential ethical issues in clinical practice guidelines for cancer treatment during pregnancy.
(1) 背景:当前科学证据表明,包括乳腺癌在内的大多数癌症在孕期都可得到治疗,且不会危及母婴结局。然而,这引发了有关临床护理伦理意义的问题。(2) 方法:通过系统的文献检索,选取了2002年至2021年间发表的32份孕期癌症治疗临床实践指南进行分析,其中25份在为临床医生提供临床管理指导时提及或参考了医学伦理学。(3) 结果:确定了四个生物伦理主题:尊重患者自主权、平衡母婴受益的方法、保护弱势群体以及资源分配中的公平性。大多数指南建议告知孕妇基于现有证据的治疗选择,并在决策过程中提供咨询和支持。大量现有指南也认可并支持孕妇自主权的关系层面。(4) 结论:认可并支持患者自主权及其关系层面应仍是未来临床实践指南的一个组成部分。然而,在处理孕期癌症治疗临床实践指南中现存和潜在的伦理问题时,需要一种更有条理的方法。